The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

Completed

Conditions studied: Coronary Artery Bypass Grafting, Heart Diseases, Heart Valve Diseases

In brief

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Key facts

Study ID

NCT00226265

Run by

Weill Medical College of Cornell University

People needed

50

Starts

1999-01-01

Expected to finish

2007-09-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cardiac surgery patients who are between the ages of 18 and 100
• Are English speaking
• Able to give consent
• Undergoing cardiac surgery including (but not limited to):
• Aortic valve replacement (AVR)
• Mitral valve replacement (MVR)
• Tricuspid valve replacement (TVR)
• Coronary artery bypass graft (CABG).

You may not qualify if…

• Non-cardiac surgery patients

Where it is running

• The New York Presbyterian Hospital-Weill Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.